ArticleClinical lymphoma, myeloma & leukemia2026

Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma.

Matthew J Rees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.